Results 81 to 90 of about 26,085 (201)
Exceptional Response of HER2‐Positive Breast Cancer to Osimertinib: A Case Report
An 83‐year‐old woman with synchronous EGFR L858R‐mutated lung adenocarcinoma and HER2‐positive breast cancer received osimertinib monotherapy for lung cancer without breast‐directed therapy. The breast tumor showed durable radiological and metabolic regression, with a Grade 3 therapeutic effect and HER2 amplification confirmed at postmortem biopsy ...
Hirotoshi Yasui +10 more
wiley +1 more source
TANC1::HTRA1 fusion in schwannomas
Brain Pathology, Volume 36, Issue 5, September 2026.
Ilay Caliskan +3 more
wiley +1 more source
Summary of the Asia Pacific Advanced Prostate Cancer Symposium 2025, showing disciplines and diversity of participants, discussion topics (high‐risk localized/locally advanced prostate cancer; PSA persistence and recurrence; radioligand therapy; genetics and genomics; bone protection and other aspects of supportive care), key themes, and high‐level ...
Edmund Chiong +28 more
wiley +1 more source
Triple-negative breast cancer (TNBC) is traditionally treated with systemic chemotherapy, often resulting in significant off-target toxicity. In this study, we assess the efficacy of intraductal chemotherapeutic delivery, aimed at reducing systemic side ...
Xinhong Wu +7 more
doaj +1 more source
Active surveillance for intermediate risk prostate cancer: the Manitoba Prostate Center experience
Objectives To report long‐term oncological outcomes of men with intermediate‐risk prostate cancer managed with active surveillance at a single centre. Subjects/Patients and Methods We retrospectively analysed a prospectively maintained Manitoba Prostate Centre active surveillance database.
Steven Lu +3 more
wiley +1 more source
Abstract Pancreatic neuroendocrine tumors (PanNETs) are increasingly detected, and the optimal extent of resection remains uncertain because perioperative burden and oncologic assessment may differ by procedure. Enucleation (EN) and central pancreatectomy (CP) are often grouped together as parenchyma‐sparing resections (PSRs) despite substantial ...
Aya Maekawa +20 more
wiley +1 more source
Pancreatic Cancer—Advances in the Last 50 Years
World Journal of Surgery, Volume 50, Issue 8, Page 2106-2115, August 2026.
S. George Barreto +5 more
wiley +1 more source
Intraductal Papillary Carcinoma
Jolinda, Mester +3 more
openaire +2 more sources

